This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Mats Hertel: Pharmaceutical Invention for Pulmonary Drug Delivery
Introduction
Mats Hertel is an inventor associated with Bad Homburg vor der Höhe, Germany, and AstraZeneca AB. His patent work concerns pharmaceutical formulations designed for pulmonary delivery.
Latest Patents
Hertel is named on one patent, 1 patent: “Dry Powder Formulation for Pulmonary Delivery and Methods of Use.” The invention describes pharmaceutical compositions for administering a JAK inhibitor to the lungs, including dry powder formulations containing a JAK inhibitor and an agglomerated lactose carrier. It also covers methods for preparing and using the compositions, along with related kits and dosage forms.
Career Highlights
Hertel’s listed patent reflects work in pharmaceutical formulation and pulmonary drug delivery. The disclosed approaches address the preparation and administration of inhalable JAK inhibitor compositions.
Collaborations
The listed coworkers associated with Hertel include Laura Forster and Christoph Gremmel.
Conclusion
Mats Hertel’s patent contribution focuses on dry powder formulations for pulmonary delivery, highlighting an approach to administering JAK inhibitors through inhalable pharmaceutical compositions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile